Service | Pythia Biotech Co., Ltd.

Customized organ chip

Accurately simulates the human physiological or pathological environments.

Pythia Biotech Ltd. provides organ-on-chips that simulate the physiological and pathological environments of the human body, which can be used as models for academic research or drug testing. Through our professional services, your R&D department can accelerate product development and reduce R&D expenses.

CUSTOMIZED

Customized service

Customized
bio-chips

Want to develop a invitro lung and blood vessel model to study the physiological cues.

Learn More →

Customized drug
screening test

You would like to test your newly developed drug but

Animal model is not relevant
Time consuming
Costly

Learn More →

Personalized
treatment *

In the future, personalized treatment will rely on proper regulations. A chip made from a patient’s own cells, will allow drug testing to be performed on the patient through the chip.

Learn More →

* In the future, personalized treatment will be achieved with the support of appropriate regulations.

An efficient platform for drug testing

Can't rely on animal tests ?

Failed animal tests due to relevance ?

Shortcoming of traditional cell culture platforms

Customized drug screening test

Pharmaceutical companies can now adopt our organ chips as the primary testing platform for drug development, replacing the reliance on cells, animals, and even platforms where human testing is not feasible. Our organ chips accurately simulate the microenvironment of human organs such as the liver, lungs, etc., providing a more realistic and reliable testing environment that aids in the assessment of drug safety and efficacy.

Personalized Cancer Treatment

with Tumor-on-a-Chip Technology

Our advanced microfluidic technology simulates your patient's tumor and immune environment using a small sample of tumor and immune cells. This allows us to quickly test multiple drug candidates in just two weeks, offering precise, personalized treatment options without the need for invasive biopsies. By screening drug combinations efficiently, we help doctors make faster, more accurate clinical decisions—improving outcomes and accelerating recovery.